chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: MMR
Symptoms: Rash generalised, Rash morbilliform, Rubella antibody negative, Vomiting
Clinical narrative: Information has been received from a registered nurse concerning a 60 year old female patient with cancer, on chemotherapy, allergy to DILAUDID and penicillin, and a history of thymectomy, "9 months ago", who on 03-FEB-2011 was vaccinated with a first dose of MMR II. There was no concomitant medication. The nurse reported that the patient developed nausea, vomiting, diarrhea a rash on her face and neck with joint pain and swollen lymph nodes. The nausea diarrhea and vomiting occurred on 12-FEB-2011 and 13-FEB-2011 and then resolved. The patient then developed a rash on her face and neck with joint pain and swollen lymph nodes on 14-FEB-2011. The rash was described as measles like rash. The rash started on the face and neck and proceeded down her body and now was a generalized rash. The patient had no previous vaccination history with MMR II, but was determined to have immunity to mumps and measles, but no immunity to German measles with an unspecified screening test. The patient sought unspecified medical attention. It was reported that on 18-FEB-2011 the patient was treated with ALLEGRA and MOTRIN. At the time of the report, the patient had not recovered from rash on her face and neck with joint pain, swollen lymph nodes and generalized rash. Additional information has been requested.
Age: 46.0
Sex: F
Vaccine: MMR
Symptoms: Glossitis, Glossodynia, Swollen tongue, Tongue blistering
Clinical narrative: Information has been received from a legal professional concerning her friend, a 46 year old female with kidney infection who on 16-FEB-2011 was vaccinated with a dose of MMR II (therapy route not reported, lot # reported as 08112, which is not valid, albumin status unknown). The patient was being treated concomitantly with BACTRIM for treatment of kidney infection. She had no relevant concomitant medications. On 17-FEB-2011 the patient began having swelling of her tongue. She also had blisters around the perimeter of her tongue and one under her tongue. Her whole tongue is sore and tongue had an appearance of being raw. On 19-FEB-2011 she sought treatment from her doctor and had 400 mg of ADVIL and had an unknown antihistamine of an unknown dose. She had no relevant laboratory tests. As of 19-FEB-2011 at 13:00, it was unknown if she had recovered from the blisters, swelling and pain in her tongue, and it was unknown if she continued to take the BACTRIM. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a female patient who on an unspecified date was vaccinated with a dose of MMR II (Lot #, expire date and route not reported). Patient stated that on an unspecified date when she was 12 month old, she experienced a reaction to MMR II. At the time of the report, patient's outcome was unknown. Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash generalised, Rash maculo-papular, Rash pruritic
Clinical narrative: Information has been received from a physician concerning a 46 year old female patient with not pertinent medical history and not drug reaction or allergies who on 02-AUG-2010 was vaccinated intramuscularly with a dose of MMR II (Lot # 666510/1624Y). There was no concomitant medication. On 02-NOV-2010 the patient experienced maculopapular pruritic rash "from head to toe" and fever of 101.5. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. No further information is available.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information has been received from a physician concerning a 4 year old female patient with no pre-existing conditions who on 19-OCT-2010 was vaccinated with MMR II (lot number 664455/0588Z). Concomitant therapy included VARIVAX (lot number 667759/0779Z), KINRIX and MOTRIN. On an unspecified date the patient experienced erythema and induration at the injection site. The MMR II injection was given in the right upper thigh. The reporter stated that there was no adverse event related to the other vaccination products. On an unknown date the patient recovered from erythema and induration at the injection site. No lab diagnostics studies were performed. The patient sought unspecified medical attention. No further information is available.
Age: 5.0
Sex: M
Vaccine: DTAP, FLUN3, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a 5 year old male with no pertinent medical history and no drug reaction and allergies who on 02-NOV-2010 was vaccinated subcutaneously with MMR II (Lot number 667247/0576Z, expiration date unknown). There was no concomitant medication. On 04-NOV-2010 the patient presented to the physician office with a red and raised rash that was warm to touch at the injection site on his right leg. The nurse reported that the patient stated it had gotten larger since the reaction started. Nurse practitioner prescribed the patient antibiotics. There was no lab diagnostics studies performed. At the time of reporting, the patient was not recovered. Follow up information was received from an advanced registered nurse practitioner (ARNP) concerning the 5 year old boy student who with no known illness at the time of vaccination or adverse event following prior vaccination on 02-NOV-2010 was vaccinated with the second dose of MMR II (Lot number 667247/0576Z) in his right leg. On 02-NOV-2010 the patient was also vaccinated with the second dose of VARIVAX (MSD) (lot number 668458/0968Z) in his left leg. On the same day, concomitant therapy included the first dose of FLUMIST intranasal (lot number 501045P) nasal inhalation, TRIPEDIA (lot number U3470CA) in his right leg and IPOL (lot number EB204) in his left leg. On 04-NOV-2010 the patient developed a raised red warm erythematous area of entire lateral and medial right upper thigh. Left upper thigh had second circle of light red and warm eruption but much less than right. On 06-NOV-2010 the patient recovered from all events. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from Pfizer, Inc and was assigned manufacturer number 2010137550/11710635, concerning a patient who on an unknown date was vaccinated with a dose of MMR II (lot n. not reported). Caller reported that the patient experienced an "odd reaction" to MMR II. It is unknown if the patient sought medical attention. At the time of reporting the patient's outcome was unknown. This was originally reported by a nurse. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Allergy test positive, Food allergy
Clinical narrative: Information has been received from a physician concerning his son who was tested for and diagnosed with a peanut allergy on an unspecified date in approximately the year 2000. The son had been immunized with several unspecified vaccines on unspecified dates in the 1990s. It was not known whether or not the son received MMR II. The patient had sought unspecified medical attention. At the time of report, the outcome was unknown. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a consumer concerning her grandson who "2 weeks ago" on approximately 28-OCT-2010 was vaccinated with a dose of MMR II (Lot# unknown). It was reported that on an unspecified date, the patient was rushed to the emergency room with a fever of 105 that the consumer felt was caused by the vaccine. At the time of the report, the outcome of the patient was unknown. No further information is available.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Burning sensation, Dermatitis contact, Erythema, Eye swelling, Full blood count
Clinical narrative: Information has been received from a nurse concerning a 21 year old female with a history of borderline anaemia and no drug allergies who on 10-NOV-2010 received a flu shot (manufacturer unknown) as well as TDap and on 17-NOV-2010 was vaccinated with MMR II in the left arm, SC (lot # 667244/0919Z, expiration date 15-JUN-2010) for booster for negative mumps titer. Concomitant therapy included birth control (unspecified type). On 20-NOV-2010 the patient' lips became puffy, eyes became swollen/red and this progressed to a red/swollen full face. This then progressed to a diffuse, pinpoint, non-raised rash on ONLY her face. There was a burning sensation on her face and it was also itchy. No fever or myalgia was present and there was no manifestation of localized reaction at the site of injection. This was confirmed by the nurse who had seen the patient back in the office on 22-NOV-2010 (today). The patient was currently treating with BENADRYL (OTC). The patient had used a new pillow without washing the cover or applying her own pillow case for the six days prior to receiving the MMR II. Nurse practitioner believed this was a contact dermatitis reaction to the pillow and not a systemic reaction to the MMR II. The patient did not recover at the time of report. Complete blood count was performed (results not reported). Additional information has been requested.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Lip swelling, Mumps antibody test negative, Ocular hyperaemia, Pruritus, Rash
Clinical narrative: Information has been received from a nurse concerning a 21 year old female with a history of borderline anaemia and no drug allergies who on 10-NOV-2010 received a flu shot (manufacturer unknown) as well as TDap and on 17-NOV-2010 was vaccinated with MMR II in the left arm, SC (lot # 667244/0919Z, expiration date 15-JUN-2010) for booster for negative mumps titer. Concomitant therapy included birth control (unspecified type). On 20-NOV-2010 the patient' lips became puffy, eyes became swollen/red and this progressed to a red/swollen full face. This then progressed to a diffuse, pinpoint, non-raised rash on ONLY her face. There was a burning sensation on her face and it was also itchy. No fever or myalgia was present and there was no manifestation of localized reaction at the site of injection. This was confirmed by the nurse who had seen the patient back in the office on 22-NOV-2010 (today). The patient was currently treating with BENADRYL (OTC). The patient had used a new pillow without washing the cover or applying her own pillow case for the six days prior to receiving the MMR II. Nurse practitioner believed this was a contact dermatitis reaction to the pillow and not a systemic reaction to the MMR II. The patient did not recover at the time of report. Complete blood count was performed (results not reported). Additional information has been requested.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Swelling face
Clinical narrative: Information has been received from a nurse concerning a 21 year old female with a history of borderline anaemia and no drug allergies who on 10-NOV-2010 received a flu shot (manufacturer unknown) as well as TDap and on 17-NOV-2010 was vaccinated with MMR II in the left arm, SC (lot # 667244/0919Z, expiration date 15-JUN-2010) for booster for negative mumps titer. Concomitant therapy included birth control (unspecified type). On 20-NOV-2010 the patient' lips became puffy, eyes became swollen/red and this progressed to a red/swollen full face. This then progressed to a diffuse, pinpoint, non-raised rash on ONLY her face. There was a burning sensation on her face and it was also itchy. No fever or myalgia was present and there was no manifestation of localized reaction at the site of injection. This was confirmed by the nurse who had seen the patient back in the office on 22-NOV-2010 (today). The patient was currently treating with BENADRYL (OTC). The patient had used a new pillow without washing the cover or applying her own pillow case for the six days prior to receiving the MMR II. Nurse practitioner believed this was a contact dermatitis reaction to the pillow and not a systemic reaction to the MMR II. The patient did not recover at the time of report. Complete blood count was performed (results not reported). Additional information has been requested.
Age: 36.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a certified medical assistant concerning a now 36 year old female who on an unspecified date was vaccinated with a dose of MMR II (route, dose and lot# not reported) when she was younger. On an unspecified date the patient had titer done and did not have immunity. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a nurse concerning her son (now 15 year old) who in 1995 was vaccinated with MMR II (lot # not reported). Subsequently (in 1995) the patient experienced a rash. Rash went away in 24 hours after dose. The patient did not seek medical attention. No further information is expected.
Sex: M
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning an unspecified age brother who on an unknown date, was vaccinated with MMR II (route, dose and lot# not reported). Nurse reported that the unspecified age brother, who might had received one or more doses of MMR II, might had come down with a case of Mumps. The unspecified brother was not seen by a physician, but during the office visit where the unvaccinated sibling was diagnosed with Mumps, the child's mother apparently described the unspecified brother as having identical symptoms. At the time of reporting, the outcome was unknown. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Allergy test, Vaccination complication
Clinical narrative: Information has been received from a field consultant from an unspecified doctors office concerning a 12 month old male patient who on approximately 29-NOV-2010 was vaccinated with a first 0.5ml dose of MMR II (Lot# not reported), IM. The field consultant stated that a patient experienced a reaction to MMR II therapy. Allergy test was performed with no results provided. The field consultant also stated that they did not specify what the reaction was. At the time of the report, the patient's outcome was unknown. The patient sought unspecified medical attention. No further information is available.
Age: 42.0
Sex: F
Vaccine: HEP, MMR, MNQ
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, No adverse event
Clinical narrative: Information has been received from a Nurse Practitioner (N.P) concerning an "about 40" year old male patient who on 10-DEC-2010 was vaccinated with a 0.5 mL dose of MMR II (Lot # not reported). It was reported that on 01-DEC-2010, the patient had received a dose of yellow fever vaccine at an undisclosed medical office. Provider calling because there was less than the recommended one month recommended spacing between the two live vaccines. The patient sought unspecified medical attention. The outcome of the patient was unknown at the time of the report. No adverse effects reported. Follow-up information has been received from a nurse practitioner who stated that the 42 year old female (reported before as male) patient with sulfa allergy and no illness at time of vaccination and no none adverse events following prior vaccination on 30-NOV-2010, the patient was vaccinated in the "buttocks" with a dose of YF-VAX (lot# not reported) who on 10-DEC-2010, was vaccinated SQ in the left arm with the second dose of MMR II (lot# 667247/0576Z) at 14:00. On the same day, the patient was vaccinated IM in the right deltoid with the first dose of ENGERIX-B (lot# AHBVB880B) and with the first dose of MENACTRA (lot# U3508AA), IM in the left deltoid, both vaccines were given at 14:00. It was reported that on 12-DEC-2010, the patient had a rash at the injection site of MMR II which started 2-3 days after the vaccine was given. It was raised, red and itchy rash. There was no relevant diagnostic test performed. No other symptoms were reported. The patient did not seek medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 1.08
Sex: F
Vaccine: FLU3, MMR, VARCEL
Symptoms: Diarrhoea, Irritability, Lethargy, Pyrexia, Rash
Clinical narrative: Information has been received from a employee concerning her approximately 13 month old daughter with amoxicillin allergy and no other medical history who on 23-DEC-2010 was vaccinated with MMR II and FLUZONE (manufacturer unknown) shot and 2 other vaccines. On 30-DEC-2010 the patient experienced a low grade fever, was lethargic, irritable and had diarrhea and recovered in 2 days. On 06-JAN-2011 the patient experienced a rash and had not recovered from the rash as of 07-JAN-2011. No lab diagnostics studies were performed. The patient did not seek the medical attention. Follow-up information has been received from the physician indicating that on 23-DEC-2010 at 9:15 AM, the patient was vaccinated with a first dose of MMR II (lot # 667246/0907Z) subcutaneously in right arm, a first of VARIVAX (Merck) (MSD) (lot # 668318/1005Z) subcutaneously in left arm, and a first dose of FLUZONE (lot # UT3667BB) intramuscularly in thigh. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Antibody test abnormal, Measles antibody
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient who in 1982 and 1990 was vaccinated with a first and second doses of MMR II (Lot # and route not reported). In 2008 the patient was vaccinated with a third dose of MMR II (Lot # and route not reported). The nurse reported that the patient's titer was found to be "equivocal" after receiving several doses of the vaccine. The nurse reported that the titer was drawn in 2008 and 2010 but they were still "equivocal". No adverse effects were reported. It was unknown if the patient sought medical attention. Additional information has been requested.
Age: 0.18
Sex: U
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a medical assistant concerning a 9 weeks old patient "2 months old", who on 08-OCT-2010 was vaccinated subcutaneously with a 0.5mL dose of MMR II (Lot # 0407z; expiration date 18-MAR-2012). The patient was not experiencing any known symptoms. Follow up information has been received from a medical assistant. It was reported that on 08-OCT-2010 the currently 3 month old patient was vaccinated IM in the upper right thigh with the first dose of MMR II (Lot number 667243/0407Z). The medical assistant reported that the mother was concerned about the baby developing a rash after the shot was given. The patient's mother did not want the baby to be seen by the office. It was reported that the rash went away. There were no other reactions. No further information is expected.
Age: 23.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative
Clinical narrative: Information has been received from an office manager concerning a 23 year old female patient who in 1988 was vaccinated with her first dose of MMR II (lot number unknown). The office manager reported that the patient received four doses of MMR II vaccination in childhood (1988, 1989, 1990 and 1992) and she was still testing negative titers. The patient denied any adverse effects. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.28
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Diarrhoea, Gastric disorder, Rash, Skin discolouration, Vomiting
Clinical narrative: Information has been received from a consumer concerning her 15 months old son with a history of ear infection and with no drug reactions or allergies who on 17-JUN-2010 was vaccinated subcutaneously with a dose of MMR II (lot number unknown). Secondary therapy included a dose of VARIVAX (Merck) (lot number unknown). Concomitant therapy also included TYLENOL. The patient's mother stated on 18-JUN-2010 "the next day", her son had a yellow rash on the neck under the chin. The physician was notified and the patient was diagnosed with a "farmer's tan". The patient's mother also stated that on 20-JUN-2010 "two days after finding the rash" her son began vomiting and had diarrhea. The physician was notified and the patient was diagnosed with a "stomach bug". No laboratory studies were performed. On 28-JUN-2010, the patient recovered from yellow rash on the neck under the chin "farmer's tan" and on approximately 30-JUN-2010 "about a week and a half" the patient recovered from "stomach bug". Additional information has been requested.
Age: 29.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test positive, Rubella antibody positive
Clinical narrative: Information has been received from an office manager concerning a 29 year old male with no pertinent medical history, no known allergies and his prior vaccination history was unknown who on an unspecified date was vaccinated with a dose of MMR II (LOT# not reported). On 14-OCT-2010 the patient had titers drawn for measles, mumps and rubella antibodies. The office manager further reported that the patient tested negative for measles antibodies, while having appropriate levels of mumps and rubella antibodies. As any vaccinations were administered by a former healthcare provider, the office manager was unable to provide any details of prior vaccinations. Office Manager did not know if the patient received MMR II as a child. The patient sought medical attention by office visit. At the time of this report, the patient was recovering. Additional information has been requested.
Age: 1.22
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash generalised
Clinical narrative: Information has been received from a healthcare worker concerning a 13 weeks old male with ear infection and no drug reactions/allergies who on 07-OCT-2010 was vaccinated with a dose of MMR II (LOT# 667006/0256Z). On the same day the patient received AUGMENTIN to treat an ear infection. On 17-OCT-2010 the patient experienced rash and fever. Ear infection had not "cleared up". The patient sought medical attention via coming to the office. The outcome of rash and fever were not reported at the time of this report. Follow-up information has been received from the healthcare worker who reported that the 15 month old (previous reported as 13 weeks old) male patient with right otitis media at time of vaccination who on 07-OCT-2010 was vaccinated subcutaneously at right arm with the first dose of MMR II (LOT# 667006/0256Z). On 18-OCT-2010 (also reported as 17-OCT-2010) the patient broken out with rash over entire body. The patient was also on AUGMENTIN X10 days for right ear infection. No lab tests were performed. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
Age: 39.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative, No therapeutic response
Clinical narrative: Information has been received from a health department nurse concerning a 39 year old female who in 1973 and in 1978 was vaccinated with the first and second dose of MMR II (LOT# not reported), respectively. In July 2010, the patient was vaccinated with the third dose of MMR II (albumin status unknown) (LOT# not reported). Titer was drawn on unspecified date, and the patient failed to seroconvert. Unspecified medical attention was sought. The patient's outcome was unknown at the time of this report. No further information is available.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test positive, Rubella antibody positive
Clinical narrative: Information has been received from a registered nurse concerning a 26 year old female patient with psoriasis and allergy to animal dander, who on unspecified dates when she was a child was vaccinated with two doses of MMR II (Lot # not reported) (manufacturer unknown) and on 04-NOV-2008 was vaccinated with a 0.5 ml dose of MMR II (Lot # 659705/0356X). A MANTOUX SKIN TEST was also administered on 04-NOV-2008. The nurse stated that the patient had a negative measles titer in November 2008, and received a dose of MMR II (Lot # 659705/0356X) on 04-NOV-2008 (after the negative measles titer). This patient again had a negative measles titer on 18-OCT-2010. Titers for mumps and rubella were within normal limits both times that titers were drawn. The patient visited an office for blood test. At the time of the report, the outcome of the patient was unknown. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: DTAPIPVHIB, MMR, PNC, VARCEL
Symptoms: Pruritus, Pyrexia, Rash generalised
Clinical narrative: Information has been received from a medical assistant concerning a 26 month old male with no medical history or drug reaction/allergies, who on 27-SEP-2010 was vaccinated with the first 0.5 ml dose of MMR II (lot # 666844/0036Z) subcutaneously. Other suspect therapy included VARIVAX (MSD). Concomitant therapy included PENTACEL and PREVNAR. On 05-OCT-2010 the patient experienced rash and fever after receiving his first dose of MMR II. No lab/diagnostics studies were performed. At the time of reporting, the outcome of rash and fever was unknown. On an unspecified date the patient sought medical attention via office visit. The reporter requested a lot check for MMR II (lot # 666844/0036Z). A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Follow-up information has been received from the medical assistant concerning a 26 month old male with otitis media and no medical history or drug reaction/allergies, who at around 2:30 p.m. on 27-SEP-2010 was vaccinated with the first 0.5 ml dose of MMR II (lot # 666844/0036Z) subcutaneously into his right arm. Other suspect therapy included VARIVAX (MSD, lot# 666862/0605Z) subcutaneously into his right arm at around 2:30 p.m. on 27-SEP-2010. On 05-OCT-2010, about 8 days after vaccination, rash started. The patient came to office on 09-OCT-2010 and returned on 10-OCT-2010 due to worsening of rash which was all over entire body, excluding palms and soles. The patient had been treated with CLARITIN and BENADRYL for itch. At the time of the reporting, the patient had recovered from the events. This is one of several reports received from the same source. Additional information is not expected.
Age: 1.24
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a medical assistant concerning a 15 month old male with penicillin allergy who on 14-OCT-2010 was vaccinated with the first 0.5 ml dose of MMR II (lot # 668015/0810Z) subcutaneously. Other suspect therapy included VARIVAX (MSD). Other concomitant therapy included PREVNAR. On 21-OCT-2010 the patient experienced rash and fever after receiving his first dose of MMR II. No lab/diagnostic studies were performed. The patient's rash and fever persisted. On an unspecified date the patient sought medical attention via office visit. The reporter requested a lot check for MMR II (lot # 668015/0810Z). A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. This is one of the several reports received from the same source. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Blood aluminium
Clinical narrative: Information has been received from a consumer concerning her approximated 12 month old daughter who in 2003 was vaccinated with a dose of MMR II (lot # 645624/0274N). In 2003, the patient's mother saw a holistic healer and they said to have her daughter checked for the presence of aluminum in her body. The patient's mother reported that she believed the vaccine was responsible for aluminum in her body. At the time of the report, the patient's outcome was unknown. Additional information is not expected.
Age: 49.0
Sex: M
Vaccine: MMR
Symptoms: Measles post vaccine
Clinical narrative: Information has been received from a physician concerning a 49 year old male patient who on an unspecified date was vaccinated with a dose of MMR II (Lot # not reported). On an unspecified date the patient developed measles. Source of exposure was unknown. The patient's outcome was not reported. Patient sought medical attention by a visit to the physician. No further information is available.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Measles, Oedema peripheral, Pyrexia, Rash erythematous, Rash generalised
Clinical narrative: Information has been received from a certified medical assistant concerning a 31 month old male with no pertinent medical history and on known drug allergies who on 19-OCT-2010 was vaccinated subcutaneously in the left thigh with the first 0.5 ml dose of MMR II (lot# 664795/0442Z). There was no concomitant medication. On 27-OCT-2010 the patient developed a fever of 101.9 degree at night and had a rash over the "whole body" in the next morning. On 28-OCT-2010 the patient was seen at office and the physician "suspected the rash was measles". At the office visit on 28-OCT-2010 there was no fever detected and the rash was described as red raised rash over the entire body that was not itchy. At the time of the report, the patient's outcome was not recovered. No diagnostic laboratory tests were performed. Follow-up information from a physician's assistant indicated that the patient with no illness at time of vaccination received the vaccine at 1:00 PM on 19-OCT-2010. Onset of fever was at 1:00 PM, on 27-OCT-2010 with a rash all over body in the next morning. The patient was seen at office with a red blanching rash mostly on face, ears and extremities. Mild swelling was noted in feet and hands. The temperature was normal as 97.7 axillary. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Rash, Urticaria
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient who on 13-OCT-2010 was vaccinated with a dose of MMR II (dose, route and lot# not reported). On 28-OCT-2010 the patient developed hives and rash 15 day after receiving vaccine injection. The patient called physician for medical attention. At the time of the report, the patient's outcome was not provided. No further information is available.
Age: 9.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody, Mumps antibody test negative, Rubella antibody positive
Clinical narrative: Information has been received from a bachelor of science in nursing concerning a 22 year old male patient with no pertinent medical history and no drug reactions or allergies, who on 21-JUL-1989 was vaccinated with the first dose of MMR II (Lot # no available) and on 07-OCT-1997, with the second dose of the vaccine (Lot # 622068/0593E). There was no concomitant medication. The nurse reported that a recent titer performed on 01-JUN-2010, showed measles equivocal and mumps negative. At the time of the report the patient was not recovered. Patient sought unspecified medical attention. Follow-up information was received from the nurse who reported that the patient received the third dose of MMR II on 12-JUL-2010. The nurse also reported that as of 26-JUL-2010, the patient showed positive rubella titers, negative mumps titer and negative rubella titer. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PPV, VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Information has been received from a medical assistant concerning a 12 month old female who was vaccinated with a dose of MMR II, a dose of VARIVAX (Merck, a dose of VAQTA and a dose of PNEUMOVAX 23 (manufacturer unknown). Patient had developed blisters near the injection site. No further information provided. The medical assistant also reported that other patients that had similar reaction, said she had heard about them but did not see them. She thought there was 2 more patients. She did not know what vaccines had been given (if they were Merck drugs) or any other details, other than they had blisters near the injection sites also. Additional information has been requested. This is one of several reports from the same source.
Age: 6.0
Sex: M
Vaccine: MMR
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a Registered Nurse concerning a current 20 year old male patient who on 27-JAN-1992 and on 14-SEP-1995 was vaccinated SQ with 0.5 ml first and second dose of MMR II respectively (lot number not reported). It was reported that it was recently found to have a negative antibody titer to mumps (date unspecified). The patient was administered an additional dose of MMR II on 20-JUL-2010. At the time of reporting, the patient had not recovered. The patient sought unspecified medical attention. No further information is available.
Age: 32.0
Sex: F
Vaccine: MEA
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning an approximately 32 year old female patient with penicillin allergy who in "27-MAY-198-" (last digit of date is unknown because it is illegible in chart) was vaccinated with a dose of MMR II (Lot# not reported). The nurse reported that the patient did not have titers to mumps after receiving MUMPSVAX II in June 1982. The patient was also administered ATTENUVAX on 27-APR-1982 and MERUVAX II on 06-MAY-1982. The nurse reported that the patient had immunity to measles and rubella. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a nurse concerning a female who when as a child was vaccinated with two doses of MMR II. It was protected against rubella until she recently (in approximately July 2010) became pregnant. The nurse stated that the patient now (in July 2010) had low rubella titers. No further information is available at this time of reporting. Follow-up information has been received from the nurse who stated that the patient was pregnant woman's spouse and no adverse experienced noted. Follow-up information has been received from the nurse who confirmed that the patient was the consumer's husband who possibly got an M-M-R II vaccination as a child while living in another country. He had a physical examination at an unknown physician's office and was found to have low rubella titers. On 27-JUL-2010 he presented to the clinic to receive the MMR II. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, No therapeutic response
Clinical narrative: Information has been received from a health care professional concerning a current 20 year old female patient  who in 1991 and 1994 was vaccinated with a first and second dose of MMR II (Lot # not provided). It was reported that he patient failed to seroconvert to measles. No adverse effects reported. It was unknown if the patient sought medical attention. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 36 year old female patient who was vaccinated with MMR II as a child. On an unspecified date, the patient experienced a rubella titer that was 0.1 point lower than required for professional school. Recently, the patient was given another dose of MMR II. At the time of reporting, the outcome was unknown. The patient was seen in office. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Injection site rash, Rash generalised
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male patient with pervasive developmental disorder (PDD) and mild developmental delay who at the age of 15 months was vaccinated with the first dose of MMR II and on 25-JUN-2010, was vaccinated with the second dose of the vaccine. The nurse reported that on 05-JUL-2010, the patient developed a generalized rash on his body that lasted 3 days. On 29-JUL-2010, the rash reappeared on the patient's legs. The nurse stated that the patient was evaluated at an unspecified emergency room for the rash. The outcome of the patient was not reported. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a physician concerning a nursing student who on an unspecified date was vaccinated with a dose of MMR II (Lot#: not reported). The physician stated that the nursing student had had titers drawn prior to admission to nursing school. The titers were not at an acceptable level. At the time of the report the patient's status was unknown and it was unknown if the patient sought medical attention. Follow-up information was received from the physician who stated that no patient had a reaction to MMR II. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a licensed practical nurse concerning a "50 year old" female who was vaccinated with 2 doses of MMR II as a child, but now had negative titers to mumps. No other adverse reaction reported. The outcome was not reported. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a mother concerning her now 25 year old son who was vaccinated with MMR II as a child. The patient had "severe reactions" when he was got the vaccination. At that time, her son experienced fever, rashes and was "crabby like a bag of cats". The titer was drawn and showed he did not have rubella immunity. It was unknown if the patient sought medical attention. At the time of the reporting, the patient's status was unknown. No further information is available.
Age: 38.0
Sex: M
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a 38 year old male patient who on an unspecified date was vaccinated with a SC 0.5 ml dose of MMR II. The nurse reported that the patient did not receive immunity to rubella after being administered MMR II. No adverse reactions were reported. At the time of the report, the patient's outcome was unknown. It was unspecified if the patient sought medical attention. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a physician concerning a female patient who on an unspecified date received a dose of MMR II (Lot # not provided) and subsequently developed negative measles titers after receiving the vaccine. At the time of this report, the patient's outcome was unspecified. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information is not expected.
Age: 51.0
Sex: F
Vaccine: MMR
Symptoms: Lymphadenopathy, Measles antibody negative, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 51 year old female who had a history of an unknown reaction to an unknown tetanus vaccine (Manufacturer unknown) when she was a child and in August 2009 "one year ago", was vaccinated with a first dose of MMR II. The physician reported that the last year the patient developed a fever and swollen glands in her neck after her first dose of the vaccine. The physician also stated that a "recent titer" showed that the patient was still not immune to measles. On unspecified date, the patient recovered from fever and swollen glands in her neck. The patient sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a 19 year old female patient who on an unspecified date, when she was younger was vaccinated with two doses of MMR II. (Lot # and routes not provided). The nurse reported that the patient now had low measles titer. At the time of the report, the patient outcome was unknown. The patient sought medical attention by visiting the physician's office. This is one of the several reports from the same source. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a physician concerning a 23 year old female who was vaccinated with the dose(s) of MMR II. On an unspecified date, the patient had done titers for measles, mumps and rubella and revealed that she did not have titers for measles, mumps or rubella. The physician noted that the patient needed to give a booster of MMR II. Unspecified medical attention was sought. No additional information is available at this time of reporting. Follow-up information has been received from a physician who reported that he/she did not administered the MMR II to the patient. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: C-reactive protein normal, Full blood count normal, Joint swelling, Pain, Red blood cell count normal
Clinical narrative: Information has been received from a physician and father of the patient concerning a 4 year old female who on 17-AUG-2010 was vaccinated with a dose of MMR II in the right deltoid. There was no concomitant medication. 10 days later on 27-AUG-2010 the patient developed swelling and discoloration in both ankles. Little tenderness/pain was noted. The patient was brought to the emergency room where labs (serum C-reactive protein test, complete blood cell count, erythrocyte sedimentation rate) were analyzed and all were negative. This presentation persisted. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Skin discolouration, Tenderness
Clinical narrative: Information has been received from a physician and father of the patient concerning a 4 year old female who on 17-AUG-2010 was vaccinated with a dose of MMR II in the right deltoid. There was no concomitant medication. 10 days later on 27-AUG-2010 the patient developed swelling and discoloration in both ankles. Little tenderness/pain was noted. The patient was brought to the emergency room where labs (serum C-reactive protein test, complete blood cell count, erythrocyte sedimentation rate) were analyzed and all were negative. This presentation persisted. Additional information has been requested.
Age: 1.15
Sex: F
Vaccine: MMR, PNC, TDAP, VARCEL
Symptoms: Pyrexia, Rash generalised
Clinical narrative: Information has been received from a physician concerning a 13 month old female patient who on 19-AUG-2010 was vaccinated with a dose of MMR II, a dose of VAQTA (MSD) and a dose of VARIVAX (MSD). Concomitant therapy included PREVNAR. On 19-AUG-2010, the patient experienced full body rash while being administered with the vaccines. The physician said the patient had a tendency for hives. At the time of the report the patient had recovered. No lab diagnostic studies were performed. Patient did not seek medical attention. Follow up information has been received from the physician concerning the 13 month old female patient with teething at the time of vaccination and a history of getting hives from bananas who on 19-AUG-2010 was vaccinated with the first dose into the right arm of MMR II (Lot # 666824/0034Z) (Route not reported). On the same day, the patient was vaccinated with the first dose into the right arm with of VARIVAX (Merck) (Lot # 665974/0068Z) (Route not reported). Concomitant vaccine given on the same day included a first dose of BOOSTRIX (Lot # AHAVB431BA) and a third dose of PREVNAR (Lot # E47474) both given into the left arm. The physician reported that on 30-AUG-2010 a rash started. On approximately 27-AUG-2010 2-3 night previous to 30-AUG-2010 the patient had fever. On an unspecified date temperature taken at the doctor's office revealed 98.8F. The patient was treated with warm bath and CALAMINE LOTION. She was diagnosed with a not specified rash. On an unspecified date, the patient had recovered. No further information is expected.
Age: 5.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site vesicles, Injection site warmth
Clinical narrative: Information has been received from a consumer concerning her 5 year old daughter with gluten allergy and penicillin allergy who on 23-AUG-2010 was vaccinated with the second dose of MMR II (lot number not provided). The consumer reported that the arm in which MMR II was administered was uncertain. Secondary suspect therapy included a dose of VARIVAX (manufacturer unknown) (lot number not provided), the arm in which it was administered was uncertain. There was no concomitant therapy. The consumer reported that on 23-AUG-2010 her daughter experienced a raised bumpy rash with lines in it on her right arm. The consumer reported that her daughter's arm was heated, had mild swelling, and blisters. The consumer also reported that her daughter's left arm presented a red oval rash at the injection site which was also heated. The consumer reported that the rash on her daughter's left arm had begun to fade, but that the rash on her daughter's right arm was still present. At the time of the report the patient had not recovered. No laboratory tests were performed. The patient sought unspecified medical attention. No further information is available.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Reaction to drug excipients
Clinical narrative: Information has been received from Pfizer, Inc and was assigned manufacturer report Number 2010107176 for PREVNAR. A 12 month old female patient was vaccinated with a dose of MMR II (lot number not provided) on an unspecified date. Concomitant therapy included two more vaccines and a dose of PREVNAR. The patient's mother reported that her daughter had a reaction to the vaccines. Upon further testing it was decided that the patient had a reaction to the gelatin in MMR II. At the time of the report the patient's outcome was unknown. It was unspecified if the patient sought medical attention. This was originally reported by a consumer. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a nurse practitioner concerning a female patient who on an unknown date was vaccinated with MMR II (Lot number 665095/0839Y). Nurse practitioner reported a patient self reported being given MMR II but the patient showed susceptibility to rubella. The nurse practitioner also stated she gave the patient a dose of MMR II but the patient was still showing susceptibility to rubella. It was unknown if the patient sought medical attention. At time of reporting, the patient's outcome was unknown. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a physician concerning an approximately 10 year old female patient (Now 20 year old) with morbidly obese and no drug reactions or allergies who on 02-MAY-1991, was vaccinated with a dose of MMR II (Lot# not reported) and on 03-AUG-2001, the patient was vaccinated with a another dose of MMR II (Lot# not reported). On 26-AUG-2010, a MMR titer test was done and showed lack of immunity to rubeola. It was unknown if the patient sought medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.